Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04692974
Other study ID # H-20-038
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 15, 2020
Est. completion date August 2021

Study information

Verified date April 2021
Source National University, Singapore
Contact Savannah Siew, BSc (Hons)
Phone 90697618
Email savannahsiew@nus.edu.sg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study intends to determine if smart watches and mobile phone application prompts can complement physical activity as a preventive intervention by motivating participants to exercise, so as to improve their physical and cognitive outcomes. The investigators hypothesize that technology will help increase engagement in physical activity for the intervention group relative to the control group and subsequently improve cognitive and physical outcomes.


Description:

This study aims to explore the role of technology -- in the form of smart watches and mobile phone application -- in physical activity enhancement on cognitive frailty outcomes. Cognitive frailty is defined here as having both physical frailty and cognitive impairment but does not satisfy criteria for Major Neurocognitive Disorder. The investigators postulate that for older adults, such technology will help increase engagement in physical activity with subsequent improvement in cognitive and physical outcomes at follow up. This is with the aim of preventing this particular group from deteriorating to cognitive frailty because of the accompanying increased risk for adverse outcomes and morbidity. This pilot study will be a randomized control trial with 2 treatment arms. Assessments will be done prior to and following the intervention period. During the period of intervention, the wearable will act as a tracking device and will be paired with a mobile application to issue prompts to the participant when necessary. The independent variable explored in the study is the use of the wearable while the levels of physical and cognitive improvements are the dependent measures. These will be tracked at baseline, 3 months and 6 months. Additionally, the mediating variable measured is the levels of physical activity to ensure that the proposed outcomes are affected through an increased level of physical activity encouraged by the use of the device. If innovations like technology and the role of self-management proves efficacious, the future of healthcare in the context of a rapidly aging population will be more sustainable. Furthermore, this supporting role of technology in positive behavioral modification amongst older adults can have a multitude of applications in subsequent healthcare interventions.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 2021
Est. primary completion date August 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 85 Years
Eligibility Inclusion Criteria: - Older adults aged 60 to 85 years Exclusion Criteria: - Engages in vigorous exercises as determined by having more than 0 minutes of vigorous exercise on the International Physical Activity Questionnaire (IPAQ). - Has medical contraindications for exercising, including but not limited to: physical disabilities or heart conditions where the primary doctor disallows exercising at moderate intensity. - Does not own an Android phone which can support at least a version 6.0 Operating System

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mobile phone application and smart watch
Mobile phone application prompts

Locations

Country Name City State
Singapore Hannah Senior Activity Center Singapore

Sponsors (2)

Lead Sponsor Collaborator
National University, Singapore Sengkang General Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Other Control variable of sleep quality as measured on the Pittsburgh Sleep Quality Index (PSQI) at 3 and 6 months Self-reported questionnaire on sleep quality in the last month. Global score ranges from 0-21 with a score of 5 and above indicating poor sleep quality. The higher the score, the poorer the sleep quality. At 3 months and 6 months
Other Control variable of levels of motivation as measured on the Barriers Self-efficacy Scale at 3 and 6 months Self-reported questionnaire on levels of motivation specific to exercising. Scores ranges from 0-100. The higher the score, the higher the level of self-efficacy. At 3 months and 6 months
Other Control variable of depression as measured on the Geriatric Depression Scale at 3 and 6 months Self-reported screening test for depression. Scores ranges from 0-15 and a higher score reflect more depressive symptoms. At 3 months and 6 months
Other Control variable of anxiety as measured on the Geriatric Anxiety Inventory at 3 and 6 months Self-reported screening test for anxiety. Scores ranges from 0-20 and a higher score reflect more anxiety symptoms. At 3 months and 6 months
Primary Mean Change from Baseline in frailty screening scores on the FRAIL questionnaire at 3 and 6 months 5 questions on fatigue, resistance, ambulation, illness and loss of weight. It is a simple screening test for frailty. Scores of 0 (non-frail), 1-2 (pre-frail) and 3-5 (frail). At 3 months and 6 months
Primary Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months Hand grip strength in kilograms At 3 months and 6 months
Primary Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months Gait speed, time taken to walk a specified distance as fast as possible, in seconds At 3 months and 6 months
Primary Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months Timed Up and Go (TUG), time taken to stand up from a chair, walk 3 meters, turn around and sit back down, in seconds At 3 months and 6 months
Primary Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months Chair Stand Test, time taken to stand up fully 5 times from a chair in seconds At 3 months and 6 months
Primary Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months Rey Auditory Verbal Learning Test (RAVLT) assesses verbal learning and memory At 3 months and 6 months
Primary Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months Digit Span Forward and Backward (DS) assesses working memory capacity At 3 months and 6 months
Primary Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months Colour Trails Test (CTT) assesses visual-spatial skills and attention At 3 months and 6 months
Primary Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months Wechsler's Block Design (WBS) assesses visuospatial ability At 3 months and 6 months
Primary Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months Semantic Fluency - animals (SFA) assesses semantic memory At 3 months and 6 months
Secondary Mean Change from Baseline in Steps Taken measured by the smart watch at 3 months and 6 months Number of steps taken daily At 3 months and 6 months
Secondary Mean Change from Baseline in moderate exercise measured by the smart watch at 3 months and 6 months Minutes of moderate exercise in a week At 3 months and 6 months
Secondary Mean Change from Baseline in levels of physical activity measured by the "International Physical Activity Questionnaire" at 3 months and 6 months Self-reported minutes and hours of vigorous or moderate exercise At 3 months and 6 months
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A